Extended adjuvant tamoxifen for early breast cancer: a meta-analysis.
<h4>Background</h4>Hormone receptor positive breast cancer is characterized by the potential for disease recurrence many years after initial diagnosis. Endocrine therapy has been shown to reduce the risk of such recurrence, but the optimal duration of endocrine therapy remains unclear.&l...
Saved in:
| Main Authors: | Mustafa Al-Mubarak, Ariadna Tibau, Arnoud J Templeton, David W Cescon, Alberto Ocana, Bostjan Seruga, Eitan Amir |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2014-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0088238&type=printable |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Interaction between Hormonal Receptor Status, Age and Survival in Patients with BRCA1/2 Germline Mutations: A Systematic Review and Meta-Regression.
by: Arnoud J Templeton, et al.
Published: (2016-01-01) -
Activation of the PI3K/mTOR/AKT pathway and survival in solid tumors: systematic review and meta-analysis.
by: Alberto Ocana, et al.
Published: (2014-01-01) -
Excellent outcomes with adjuvant toremifene or tamoxifen in early stage breast cancer
by: Jaime D. Lewis, et al.
Published: (2014-11-01) -
Evaluation of the androgen receptor in patients with ERα-positive early breast cancer treated with adjuvant tamoxifen ± fluoxymesterone
by: James N. Ingle, et al.
Published: (2025-03-01) -
Features of ovarian steroidogenesis and endometrial hypertrophy during adjuvant therapy with tamoxifen in premenopausal patients with hormone-dependent breast cancer
by: A. Yu. Goryainova, et al.
Published: (2023-05-01)